US Patent 11459300 Deuterated compounds and uses thereof
Patent 11459300 was granted and assigned to Aldeyra Therapeutics on October, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11459300 Deuterated compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
